echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Stroke: After heart transplantation, what are the risk factors and outcome of stroke?

    Stroke: After heart transplantation, what are the risk factors and outcome of stroke?

    • Last Update: 2021-09-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Ischemic stroke and transient ischemic attack are the most common cerebrovascular complications after heart transplantation (HT)


    Vascular Immunity

    Recently, it has been shown that switching to sirolimus is associated with a significant decrease in the progression of vascular disease in heart transplantation when CNI treatment is completely stopped


    In view of the effect of sirolimus on the vascular bed, the effect of sirolimus on the risk of stroke may be mediated by reducing the stenosis of extracardiac blood vessels in the brain, and there is no research yet


    In this way, Hilmi Alnsasra and others of the Mayo Clinic explored whether immunosuppression from CNI to sirolimus is related to the decrease in the incidence of stroke, and evaluated the incidence, risk factors and prognostic significance of stroke in the HT population


    They retrospectively analyzed the incidence of ischemic and hemorrhagic strokes and related results in all consecutive HT recipients transplanted in an institution from 1994 to 2016


    Of the 529 patients who received HT, 57 (10.


    They found that age at HT (adjusted hazard ratio [HR]1.


    diabetes

    Patients with stroke (any type) are more likely to have worse renal function (HR, 1.


    Stroke

    Cytomegalovirus infection is associated with an increased risk of any stroke (HR, 2.


    Infection with calcineurin inhibitors compared maintenance therapy, the calcineurin inhibitor is converted to significant changes in immunosuppression and risk of stroke based on independent sirolimus (the HR, 1.


    The significance of this study lies in the discovery: Stroke after HT is related to an increase in mortality


    Stroke after HT is associated with an increase in mortality






    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.